| Immunomodulatory activity of nivolumab in metastatic renal cell carcinoma TK Choueiri, MN Fishman, B Escudier, DF McDermott, CG Drake, ... Clinical Cancer Research 22 (22), 5461-5471, 2016 | 295 | 2016 |
| Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancer DG McNeel, EJ Dunphy, JG Davies, TP Frye, LE Johnson, MJ Staab, ... Journal of Clinical Oncology 27 (25), 4047-4054, 2009 | 286 | 2009 |
| Potentiating endogenous antitumor immunity to prostate cancer through combination immunotherapy with CTLA4 blockade and GM-CSF L Fong, SS Kwek, S O'Brien, B Kavanagh, DG McNeel, V Weinberg, ... Cancer Research 69 (2), 609-615, 2009 | 284 | 2009 |
| Pre-existent immunity to the HER-2/neu oncogenic protein in patients with HER-2/neu overexpressing breast and ovarian cancer ML Disis, KL Knutson, K Schiffman, K Rinn, DG McNeel Breast cancer research and treatment 62, 245-252, 2000 | 221 | 2000 |
| A first-in-human phase I study of subcutaneous outpatient recombinant human IL15 (rhIL15) in adults with advanced solid tumors JS Miller, C Morishima, DG McNeel, MR Patel, HEK Kohrt, JA Thompson, ... Clinical Cancer Research 24 (7), 1525-1535, 2018 | 200 | 2018 |
| Phase I trial of a monoclonal antibody specific for αvβ3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion DG McNeel, J Eickhoff, FT Lee, DM King, D Alberti, JP Thomas, A Friedl, ... Clinical Cancer Research 11 (21), 7851-7860, 2005 | 194 | 2005 |
| Preclinical pharmacokinetics and biodistribution studies of 89Zr-labeled pembrolizumab CG England, EB Ehlerding, R Hernandez, BT Rekoske, SA Graves, H Sun, ... Journal of Nuclear Medicine 58 (1), 162-168, 2017 | 181 | 2017 |
| Role of B cells as antigen presenting cells I Rastogi, D Jeon, JE Moseman, A Muralidhar, HK Potluri, DG McNeel Frontiers in immunology 13, 954936, 2022 | 156 | 2022 |
| Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma JM Lang, MR Kaikobad, M Wallace, MJ Staab, DL Horvath, G Wilding, ... Cancer Immunology, Immunotherapy 60, 1447-1460, 2011 | 156 | 2011 |
| Androgen deprivation and immunotherapy for the treatment of prostate cancer M Gamat, DG McNeel Endocrine-related cancer 24 (12), T297-T310, 2017 | 146 | 2017 |
| Delayed-type hypersensitivity response is a predictor of peripheral blood T-cell immunity after HER-2/neu peptide immunization ML Disis, K Schiffman, TA Gooley, DG McNeel, K Rinn, KL Knutson Clinical Cancer Research 6 (4), 1347-1350, 2000 | 146 | 2000 |
| Human prostate tumor antigen–specific CD8+ regulatory T cells are inhibited by CTLA-4 or IL-35 blockade BM Olson, E Jankowska-Gan, JT Becker, DAA Vignali, WJ Burlingham, ... The Journal of Immunology 189 (12), 5590-5601, 2012 | 139 | 2012 |
| DNA vaccine encoding prostatic acid phosphatase (PAP) elicits long-term T-cell responses in patients with recurrent prostate cancer JT Becker, BM Olson, LE Johnson, JG Davies, EJ Dunphy, DG McNeel Journal of immunotherapy 33 (6), 639-647, 2010 | 133 | 2010 |
| Prostate cancer patients on androgen deprivation therapy develop persistent changes in adaptive immune responses MD Morse, DG McNeel Human immunology 71 (5), 496-504, 2010 | 123 | 2010 |
| Efficacy and safety of single-agent pertuzumab (rhuMAb 2C4), a human epidermal growth factor receptor dimerization inhibitor, in castration-resistant prostate cancer after … DB Agus, CJ Sweeney, MJ Morris, DS Mendelson, DG McNeel, ... Journal of clinical oncology 25 (6), 675-681, 2007 | 120 | 2007 |
| 89Zr-labeled nivolumab for imaging of T-cell infiltration in a humanized murine model of lung cancer CG England, D Jiang, EB Ehlerding, BT Rekoske, PA Ellison, ... European journal of nuclear medicine and molecular imaging 45, 110-120, 2018 | 118 | 2018 |
| The SSX family of cancer‐testis antigens as target proteins for tumor therapy HA Smith, DG McNeel Journal of Immunology Research 2010 (1), 150591, 2010 | 116 | 2010 |
| Antibody immunity to prostate cancer associated antigens can be detected in the serum of patients with prostate cancer DG McNEEL, LAND NGUYEN, BE STORER, R VESSELLA, PH LANGE, ... The Journal of urology 164 (5), 1825-1829, 2000 | 107 | 2000 |
| Phase I trial of tremelimumab in combination with short-term androgen deprivation in patients with PSA-recurrent prostate cancer DG McNeel, HA Smith, JC Eickhoff, JM Lang, MJ Staab, G Wilding, G Liu Cancer Immunology, Immunotherapy 61, 1137-1147, 2012 | 105 | 2012 |
| ImmunoPET imaging of CTLA-4 expression in mouse models of non-small cell lung cancer EB Ehlerding, CG England, RL Majewski, HF Valdovinos, D Jiang, G Liu, ... Molecular pharmaceutics 14 (5), 1782-1789, 2017 | 98 | 2017 |
Joshua M LangProfessor of Medicine在 medicine.wisc.edu 的电子邮件经过验证
